Ikeda Yoshihiro | Second Department Of Internal Medicine Sapporo Medical University
スポンサーリンク
概要
- Ichikawa Yoshihikoの詳細を見る
- 同名の論文著者
- Second Department Of Internal Medicine Sapporo Medical Universityの論文著者
関連著者
-
Ikeda Yoshihiro
Second Department Of Internal Medicine Sapporo Medical University
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miki Takayuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department Of Internal Medicine (cardiovascular Medicine) Sapporo Medical University School O
-
MIURA Tetsuji
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miki Takayuki
Second Department of Internal Medicine, Sapporo Medical University
-
Miura Tetsuji
Second Department Of Internal Medicine Department Of Clinical Laboratory Medicine Sapporo Medical Un
-
Sakamoto Jun
Second Department of Internal Medicine, Sapporo Medical University
-
Sakamoto Jun
Second Department Of Internal Medicine Sapporo Medical University
-
坂本 淳
札幌医科大学第二内科
-
Yano Toshiyuki
Second Department of Internal medicine, Sapporo Medical University
-
Sakamoto Jun
Department Of Pharmacology School Of Medicine Sapporo Medical University
-
Yano Toshiyuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Ichikawa Yoshihiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Tanno Masaya
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Nakamura Yuichi
Second Depertment of Internal Medicine, Sapporo Medical University School of Medicine
-
Nakamura Yuichi
Second Department Of Internal Medicine Sapporo Medical University
-
Ohhori Katsuhiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Ohhori Katsuhiko
Second Department Of Internal Medicine Sapporo Medical University
-
Miki Takayuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Shimamoto Kazuaki
Second Department Of Internal Medicine Sapporo Medical University
-
Kobayashi Hironori
Second Department of Internal Medicine, Sapporo Medical University
-
Tanno Masaya
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Naitoh Kazuyuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Kobayashi Hironori
Second Department Of Internal Medicine Sapporo Medical University
-
Naitoh Kazuyuki
Second Department of Internal medicine, Sapporo Medical University
-
Sakamoto Jun
Department of Pharmacology, Sapporo Medical University School of Medicine
-
Matuda Eiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Ohnuma Yoshito
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University
-
Miura Tetsuji
The Second Department Of Internal Medicine Sapporo Medical College
-
Matuda Eiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Miura Tetsuji
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Nakano Atsushi
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ohnuma Yoshito
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Sakamoto Jun
Department Of Chemistry Nara University Of Education
-
Shimamoto Kazuaki
2nd Department of Internal Medicine, SapporoMedical University School of Medicine
-
Satoh Takahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ishikawa Satoko
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Nakano Atsushi
Second Department of Internal Medicine, Sapporo Medical University
-
Miura Testuji
Second Department of Internal Medicine, Sapporo Medical University
-
Horio Yoshiyuki
Department of Pharmacology, Sapporo Medical University
-
Nishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Tanno Masaya
Depertment of Pharmacology, Sapporo Medical University School of Medicine
-
naitou kazuyuki
Second Department of Internal Medicine, Sapporo Medical University
-
Hishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Matsuda Eiji
Product Research Department, Chugai Pharmaceutical Co.
-
Saitoh Keiji
Product Research Department, Chugai Pharmaceutical Co.
-
Ohnuma Yoshito
2nd Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miura Tetsuji
2nd Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Miki Takayuki
2nd Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Nakano Atsushi
Hakodate Ishikai Hospital
-
Ichikawa Yoshihiko
2nd Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Shimamoto Kazuaki
2nd Department Of Internal Medicine Sapporo Medical University
-
Nishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University School Of Medicine
-
Horio Yoshiyuki
Department Of Pharmacology Ii Faculty Of Medicine Osaka University
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University
-
Hishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University
著作論文
- OJ-104 Connexin-43 Contributes to Pro-survival Akt/GSK-3β signaling And Cardimyocyte Protection in a Receptor-specifit Manner(Cell death, apoptosis/necrosis(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Soci
- OJ-103 Role of Intra-mitochondrial GSK-3β in Bax Regulation And Antiapoptotic Resistance of Cardiomyocytes(Cell death, apoptosis/necrosis(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-268 Ischemic Preconditioning Modifies Interactions between Connexin43 and Protein Kinases during Myocardial Ischemia(Myocardial ischemia-reperfusion, basic/clinical-4 (IHD) PE45,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
- OE-080 Role of GSK-3 β as a Crucial Determinant of Anti-infarct Tolerance of the Myocardium(Acute myocardial infarction, basic-1 (IHD) OE14,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OE-026 Activation of ERK and Suppression of Calcineurin are Interacting Mechanisms of Cardioprotection Afforded by δ-opioid Receptor Activation(Myocardial ischemia-reperfusion, basic/clinical-1 (IHD) OE5,Oral Presentation (English),The 70th Anniversary An
- Activation of δ-Opioid Receptor Suppresses Myocardial Ischemic Injury by ERK Activation during the Early Phase of Ischemia(Acute Myocardial Infarction, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Activation of the δ-opioid Receptor Induces Phosphorylation of Connexin43 at Ser368 by PKC-ε and Reduces Myocardial Infarct Size(Myocardial Ischemia-reperfusion, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Erythropoietin Reduces Myocardial Ischemic Injury, but not Reperfusion Injury, Through Activation of the Pl3k/Akt Pathway(Myocardial Ischemia-reperfusion, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PE-069 Suppression of Border Zone Remodeling by G-CSF/M-CSF Treatment Improves Ventricular Function after Infarction(Acute Myocardial Infarction, Basic 3 (IHD) : PE12)(Poster Session (English))
- OE-080 Shedding of TNF-a by Activation of ADAM17 Contributes to Activation of Tyrosine Kinase-Mediated Pathway in Ischemic Preconditioning(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-079 Suppression of Gap Junction Permeability Is a Mechanism of Cardioprotection Afforded by Activation of the Mitochondrial KATP Channel(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-003 Mechanisms of Improvement in Post-infarct Ventricular Function by M-CSF in the rat : Increased Myocyte Regeneration vs. Modulation of Infarct Repair(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
- FRS-084 Ischemia/Reperfusion Up-regulates Egr-1 Expression by an NO and ERK-mediated Mechanism in the Heart.(NO and Cardiovascular System (H) : FRS10)(Featured Research Session (English))
- Microtubules Play a Major Role in Signal Transduction in the Mechanism of Cardioprotection Afforded by Ischemic Preconditioning
- Metaloprotease-Disintegrin Is Involved in Tyrosine Kinase-Mediated Signaling in Ischemic Preconditioning